The Board of Directors of Nymox Pharmaceutical Corporation confirmed the appointment of Randall J. Lanham, Esq. as the company's Secretary and General Counsel. Mr. Lanham has been a board member for eight years and is now reappointed as a board member and an officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 USD | -7.32% |
|
-17.36% | -67.80% |
1st Jan change | Capi. | |
---|---|---|
-67.80% | 17.74M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Appointment of Randall J. Lanham, Esq. as the company’s Secretary and General Counsel